Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
Holding GDRX?
Track your performance easily
GDRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.14 - $9.26
Previous Close$7.59
Volume1.06M
Average Volume (3M)1.37M
Market Cap
$2.88B
Enterprise Value$3.06B
Total Cash (Recent Filing)$524.90M
Total Debt (Recent Filing)$707.38M
Price to Earnings (P/E)―
Beta1.61
Next Earnings
Nov 06, 2024EPS Estimate
$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding379,453,036
10 Day Avg. Volume818,603
30 Day Avg. Volume1,368,380
Standard Deviation0.20
R-Squared0.12
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)4.31
Price to Sales (P/S)3.76
Price to Cash Flow (P/CF)75.80
P/FCF Ratio165.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.95
Enterprise Value/Gross Profit4.48
Enterprise Value/Ebitda53.84
Forecast
1Y Price Target
$9.58Price Target Upside30.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
GoodRx Holdings News
PremiumCompany Announcements
GoodRx Holdings Board Restructure and New Director InductionBulls Say, Bears Say
Bulls Say
Financial PerformanceAdjusted EBITDA of $65.4mm topped Street’s estimate of $62.8mm, implying a 32.6% margin as savings from restructuring pulled through to the bottom line.
Market Share GrowthPrescription growth is exceeding overall market growth, indicating that GoodRx is continuing to gain market share.
Strategic PositioningGoodRx drives foot traffic to front-of-store, adding incentive for retail pharmacies to make deals with them, already having agreements with 7 of the top 10 retailers.
Bears Say
Retail Pharmacy ClosuresThe large and unexpected impact from Rite Aid store closures is likely to create some modest near-term pressure as patients need to re-engage with GoodRx’s app when they visit a different pharmacy.
Revenue OutlookThe revenue guide for 2024 has been trimmed to the lower end of $800-$810M due to an anticipated $5M impact from store closures.
Subscription PlansSubscription plans of 696K fell short of Street’s 720K, mainly due to the wind-down of Kroger Savings Club.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $4.13 and its highest was $9.26 in the past 12 months.
What is GoodRx Holdings’s market cap?
Currently, no data Available
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is Nov 06, 2024 which is in 48 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Aug 08, 2024. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.087 by -$0.007.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is $0.09.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 98,583,720 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.08 in its last earnings report, missing expectations of $0.087. Following the earnings report the stock price went down -18.583%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Among the largest hedge funds holding GoodRx Holdings’s share is Silver Lake Group, L.L.C.. It holds GoodRx Holdings’s shares valued at 28M.
---
GoodRx Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.58 (30.43% Upside)
$9.58 (30.43% Upside)
Blogger Sentiment
Neutral
GDRX Sentiment 58%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 6.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $618.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.3%
Last 30 Days ▼ 4.1%
Last 30 Days ▼ 4.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.50%
12-Months-Change
Fundamentals
Return on Equity
-7.50%
Trailing 12-Months
Asset Growth
-12.81%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings Inc provides digital healthcare platform that provides prescription drugs at affordable prices. The company offers services like diabetes testing, general visits, blood tests, HIV testing, Vitamin D screening, Pregnancy testing, and many more.
---
GDRX Earnings Call
Q2 2024
0:00 / 0:00
---
GDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
---
GDRX Stock 12 Month Forecast
Average Price Target
$9.58
▲(30.43% Upside)
Technical Analysis
Best Analysts Covering GDRX
1 Year
1 Year Success Rate
8/9 ratings generated profit
1 Year Average Return
+16.84%
reiterated a buy rating last month
Copying Michael Cherny's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +16.84% per trade.
---